Brentuximab is an advanced medication prescribed world over for the treatment of Haematological Malignancies including refractory Hodgkin lymphoma (HL) and systemic Anaplastic Large Cell Lymphoma (ALCL). The trade name of Brentuximab is Adcetris and it globally available as Adcetris 50mg vials. Brentuximab 50mg is stored and transported in 2 to 8 Degree temperature controlled condition to retain the efficacy of medication.
Adcetris 50mg – Duly approved by FDA and EMA
Brentuximab vedotin was approved by FDA in 2011 and EMA in 2012. It was initially promoted by Seattle Genetics for the relapsed Hodgkin Lymphoma along with Anaplastic Large Cell Lymphoma. At present Adcetris 50mg is being promoted by Takeda Pharmaceuticals in collaboration with Seattle Genetics.
- In the recent years, this medication was granted approval for the treatment of Cutaneous T-cell Lymphoma (CTCL). Clinical data suggest that patients of advanced Classic Hodgkin Lymphoma benefit from Brentuximab in combination with chemotherapy. Literature also suggests a prominent role for Adcetris 50mg injection in the treatment of relapsed cHL. As part of combination therapy, Brentuximab 50mg is also recommended for peripheral T-cell lymphomas. Relapsed aALCL is yet another approved indication.
- Bone Marrow Transplantation or Hematopoietic Stem Cell Transplantation (HSCT) is one of the most recommended therapeutic innervations by Haematologists worldwide in the management of Classic Hodgkin Lymphoma. Brentuximab is recommended as a consolidation therapy post transplant.
Brentuximab India – Availability, Cost & Access Information
Brentuximab in India has been prescribed by Hematology and BMT consultants. Patients are counseled for advanced preparation for using Adcetris in India, because of the access and availability concerns. However, accessing the relevant information like Brentuximab cost in India is a tedious task for patients and their families.
Many specialty medications or drugs are restricted for advertizing in India and therefore it would require a lot more than a simple search for Brentuximab vedotin price in India. The best way to secure an early access is to take the treating physicians help for reliable references from their patients who are already on therapy with Brentuximab in India. It helps them to save on a lot of time reaching out to various dealers and distributors who may not be provide real-time feedback. Brentuximab vedotin price also fluctuates depending on various global factors and international currency rates of conversion.
Hassle free procurement of Brentuximab in India
The procedure involving the sourcing and procurement of medicines that are yet to be approved and available in India is fully streamlined and facilitated by the Indian Drug Authorities. Import Permit in the name of patient is the pre-requisite which will be issued by CDSCO after verifying the prescription for the personal use of Brentuximab in India by a registered physician. Patients can reach out to the global suppliers and officially import Adcetris in India. The whole process may take five to ten business days, depending on the availability. Based on the recommendation of the treating consultants, it is advisable to procure the medication for the complete course of treatment. This helps in terms of better preparedness apart from saving on the shipping and logistics expenses.
Contact Noel Biotech – +91 9677010046 / +91 992977766; nhs@noelbiotech.com